TITAN PHARMACEUTICALS INC
DelistedCIK 910267fmd_0DEZRY0W77BGJK5ZQ94WKQMGS4Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2009 to Jun 30, 2025, 62 periods
Latest annual · FY2023
Millions- Total revenues
- 0
- Gross profit
- 1
- Operating income
- (5)
- Net income
- (5)
- Free cash flow
- (7)
Latest quarter · Q2 FY2025
Millions- Operating income
- (1)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- -66.4%
- Net income, 5 yearsFY2019 to FY2024
- n/m
TITAN PHARMACEUTICALS INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Operating income | -$4.6 million | -$7.3 million | 10-K 2025-03-20 · proof | |
| Net income | -$4.7 million | -$5.6 million | 10-K 2025-03-20 · proof | |
| Cash from operating activities | -$3.9 million | -$7.1 million | 10-K 2025-03-20 · proof | |
| Total assets | $2.9 million | $8.1 million | -63.9% | 10-K 2025-03-20 · proof |
| Total liabilities | $483,000 | $1.4 million | -66.6% | 10-K 2025-03-20 · proof |
| Cash and cash equivalents | $2.8 million | $6.8 million | -58.1% | 10-K 2025-03-20 · proof |
- What was TITAN PHARMACEUTICALS INC's operating income in fiscal 2024?
- TITAN PHARMACEUTICALS INC reported operating income of -$4.6 million for fiscal 2024 (the year ended Dec 31, 2024), against -$7.3 million the year before. Source: the 10-K filed with the SEC on Mar 20, 2025. SEC
- What was TITAN PHARMACEUTICALS INC's net income in fiscal 2024?
- TITAN PHARMACEUTICALS INC reported net income of -$4.7 million for fiscal 2024 (the year ended Dec 31, 2024), against -$5.6 million the year before. Source: the 10-K filed with the SEC on Mar 20, 2025. SEC
- What was TITAN PHARMACEUTICALS INC's cash from operating activities in fiscal 2024?
- TITAN PHARMACEUTICALS INC reported cash from operating activities of -$3.9 million for fiscal 2024 (the year ended Dec 31, 2024), against -$7.1 million the year before. Source: the 10-K filed with the SEC on Mar 20, 2025. SEC
- What are TITAN PHARMACEUTICALS INC's total assets?
- As of Dec 31, 2024, TITAN PHARMACEUTICALS INC reported total assets of $2.9 million, against $8.1 million a year earlier (-63.9%). Source: the 10-K filed with the SEC on Mar 20, 2025. SEC
- What are TITAN PHARMACEUTICALS INC's total liabilities?
- As of Dec 31, 2024, TITAN PHARMACEUTICALS INC reported total liabilities of $483,000, against $1.4 million a year earlier (-66.6%). Source: the 10-K filed with the SEC on Mar 20, 2025. SEC
- What are TITAN PHARMACEUTICALS INC's cash and cash equivalents?
- As of Dec 31, 2024, TITAN PHARMACEUTICALS INC reported cash and cash equivalents of $2.8 million, against $6.8 million a year earlier (-58.1%). Source: the 10-K filed with the SEC on Mar 20, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:910267&period_type=annual&limit=5"Information only, not investment advice.